Teamviewer Ag Stock Earnings Reports

Q3 '25 highlights: TeamViewer delivered pro forma revenue of ~€192m (+4% YoY, constant currency) and pro forma ARR of €757m (+4% YoY, cc). Enterprise remains the main growth engine (Enterprise ARR +12% YoY, TeamViewer stand‑alone enterprise ARR +18% YoY), while the acquired 1E business underperformed (1E stand‑alone ARR down, pipeline conversion issues and some churn), which prompted a revision to full‑year ARR guidance. Profitability stayed strong: pro forma adjusted EBITDA margin was 46% and adjusted EPS rose 15% YoY; pro forma net leverage improved to 2.8x. Product and technology progress: launches of DEX Essentials and TeamViewer One, and rollout of the TeamViewer Intelligence suite (AI opt‑ins ~9,000 customers, ~80,000 AI session summaries in September). Management actions: sales and go‑to‑market harmonization (Mark Banfield now leading global sales; Oliver Steil overseeing marketing), customer success build‑out, and immediate measures to stabilise 1E. Guidance update: full‑year 2025 ARR revised to €780–800m (lowered due to 1E operational impacts and FX), full‑year revenue still expected within prior range but at the low end (€778–797m), and adjusted EBITDA margin guidance raised to ~44% due to cost discipline. Cash/capital: levered free cash flow seasonality in Q3; FY cash conversion outlook reduced to ~60% (from earlier higher expectation). Key investor risks: 1E pipeline conversion and retention, SMB monetization adjustments (short‑term ARR impact from pausing some monetization measures), and FX headwinds impacting ARR/revenue.